Canada Markets closed

Grifols, S.A. (GIFLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
14.51+1.44 (+11.02%)
At close: 09:35AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close13.07
Open14.51
Bid0.00 x 0
Ask0.00 x 0
Day's Range14.51 - 14.51
52 Week Range7.90 - 21.00
Volume602
Avg. Volume2,486
Market Cap8.8B
Beta (5Y Monthly)0.33
PE Ratio (TTM)13.37
EPS (TTM)1.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 03, 2021
1y Target EstN/A
  • Reuters

    Grifols considers selling 2 bln euros worth of assets to cut debt, Cinco Dias says

    Spanish pharmaceutical company Grifols considers selling assets worth about 2 billion euros ($2.12 billion) to cut its debt, Cinco Dias reported on Wednesday, citing unidentified financial sources. The company may sell its Chinese business and its diagnoses unit, Cinco Dias reported. A spokesperson for the company declined to comment though in November Grifols said it was committed to reducing its 9.4 billion net debt.

  • Reuters

    Spanish pharmaceuticals firm Grifols reports 30% drop in nine-month profit

    Spanish pharmaceutical company Grifols reported a 30% drop in nine-month net profit on Tuesday, due in part to acquisition costs. Grifols said it was still on track to meet its full-year financial targets, but its shares fell 4.2% in morning trade. The company, which uses blood plasma to make medicines, saw its business severely hit by the pandemic as blood collection was halted in many countries.

  • Reuters

    Grifols says U.S. blood donors' lawsuit won't have material impact, shares down

    Spanish pharma group Grifols said on Friday a lawsuit filed in the United States by blood donors who claim the company violated their privacy would have no material impact, after a report in newspaper El Economista sent the shares sharply lower. The company said about 54,000 donors in Illinois had filed a lawsuit claiming Grifols breached data protection regulations, confirming the newspaper report. Grifols shares were down 5.3% on Friday morning, briefly the worst performer on the blue-chip Ibex-35 index, which was down 2.1%.